Amaero (3DA) EGM 2026 summary
Event summary combining transcript, slides, and related documents.
EGM 2026 summary
28 Aug, 2026Opening remarks and agenda
Meeting opened by the Chairman and CEO, confirming quorum and proper constitution of the meeting.
Notice and proxy statement were distributed to all members on August 7, 2026.
Attendance included directors, governance advisors, legal counsel, and share registry representatives.
Specific resolutions to be voted on
Adoption of the 2026 Equity Incentive Plan for a three-year period.
Approval to issue up to 5 million shares of common stock via a public offering.
Increase in the non-executive director fee pool from AUD 500,000 to $600,000 per annum.
Issuance of RSUs to Mr. Omer Granit, Mr. Erik Levy, Mr. Robert Latta, and Mr. Tim Johnson, each valued at $115,000 per year for three years.
Withdrawal of the proposal to issue stock to Mr. Hank Holland.
Corporate governance
Only the stockholder CHESS Depositary Nominees Pty Limited was entitled to vote, with voting instructions based on CDI holdings as of July 31, 2026.
Donna Bent of Computershare appointed as returning officer to conduct the poll.
Undirected proxies defaulted to the chair, who intended to vote in favor of all items.
Latest events from Amaero
- Revenue up 376% to $18.1M, but net loss widened; strong backlog amid going concern risk.3DA
H2 2026 - Record revenue growth, strong backlog, and U.S. IPO plans mark a pivotal year.3DA
Q4 2026 TU - Poised for rapid growth, Amaero leads U.S. advanced powder production and targets a U.S. IPO.3DA
IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 - Shareholders and option holders strongly approved all proposed schemes and director option grants.3DA
Scheme Meeting 2026 presentation - Q3 FY2026 revenue up 301%–347% YoY, FY2026 fully contracted, U.S. redomiciliation advances.3DA
Q3 2026 TU - FY2025 saw record revenue, major supply deals, and facility expansion, setting up strong FY2026 growth.3DA
H2 2025 - Strategic U.S. shift, capital raises, and C103 supply deals set path to EBITDA breakeven by FY2026.3DA
H2 2024 - Revenue up 367%, net loss widens, FY2026 guidance cut amid U.S. contract delays.3DA
H1 2026 - Transition to commercialization, capital raises, and U.S. expansion with new leadership.3DA
AGM 2024